American biologists from the University of Southern California was able to observe the connection between the natural process of aging in the human body, and malignant neoplasms. Experts engaged in the development of new anti-cancer drug, but suddenly received evidence that it is old age constitutes an obstacle to the development of cancer. Materials and results of these studies published Journal of Biological Chemistry.
Scientists are closely watching the process of life of various types of cancer cells, samples of which were selected from human volunteers who took part in the experiment. And as a result of the monitoring, it was found that the gene CDKN2A, which is responsible for the formation of the protein p16, was damaged.
Based on observations made turned out to deduce the following: is the protein p16 blocks the division of cancer cells. Moreover, it is blocking it until the very long as a negative process will not stop. The cells simply die, and die on the background of favorable conditions to gene mutations. That is, the protein p16, preventing the activation of cancer cells converts them into a "sleep" state. But that's a minus such developments is to initiate the body's aging process.
On these findings the researchers, of course, did not stop. They developed the original components for future anticancer drugs, detrimental effect on the cells with a deficit of useful protein. That is, those who do not have the necessary protection from potential mutation. And perhaps very soon the drug started with the participation of these components, to save mankind from the scourge of oncology.
Want to know more about medicine? Do not forget to support our channel in service Yandex. Zen Like and subscription. It motivates us to publish more interesting materials. Also, you can quickly learn about new publications.
